Effects of the T/L-type calcium channel blocker, benidipine on albuminuria plasma and aldosterone concentration: A pilot study of switching from l-type calcium channel blockers to benidipine

被引：0
作者：
Tani, S. [1 ]
Nagao, K. [1 ]
Hirayama, A. [2 ]
机构：
[1] Nihon Univ, Surugadai Hosp, Tokyo, Japan
[2] Nihon Univ, Sch Med, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P443
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
[31]   T-type and L-type Calcium Channel Blockers for the Treatment of Cardiac Iron Overload: An Update [J].
Kumfu, Sirinart ;
Chattipakorn, Siriporn C. ;
Chattipakorn, Nipon .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2017, 70 (05) :277-283
[32]   Different Effects of L/N-Type and L-Type Calcium Channel Blockers on the Renin-Angiotensin-Aldosterone System in SHR/Izm [J].
Konda, Tomoyuki ;
Enomoto, Azusa ;
Aritomi, Shizuka ;
Niinuma, Kazumi ;
Koganei, Hajime ;
Ogawa, Tetsuya ;
Nitta, Kosaku .
AMERICAN JOURNAL OF NEPHROLOGY, 2009, 30 (02) :155-161
[33]   Mouse models to study L-type calcium channel function [J].
Moosmang, S ;
Lenhardt, P ;
Haider, N ;
Hofmann, F ;
Wegener, JW .
PHARMACOLOGY & THERAPEUTICS, 2005, 106 (03) :347-355
[34]   The effect of an L-type calcium channel blocker on the hemodynamics of orbital arteries in dogs [J].
Källberg, ME ;
Brooks, DE ;
Komaromy, AM ;
Miyabayashi, T ;
Bradshaw, PT .
VETERINARY OPHTHALMOLOGY, 2003, 6 (02) :141-146
[35]   Renoprotective Advantage of an L/N-Type Calcium Channel Blocker Compared With L-Type Calcium Channel Blockers in Type 2 Diabetic Patients With Early-Stage Nephropathy [J].
Fukumoto, Shinya ;
Ishimura, Eiji ;
Takeda, Koji ;
Mima, Yohei ;
Motoyama, Koka ;
Morioka, Tomoaki ;
Mori, Katsuhito ;
Shoji, Tetsuo ;
Emoto, Masanori ;
Nishizawa, Yoshiki ;
Inaba, Masaaki .
DIABETES, 2012, 61 :A143-A144
[36]   Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker [J].
Lu, Wen ;
Zhang, Tao ;
Li, Pengfei ;
Wang, Fang ;
Pan, Xiaoyan ;
Wang, Chen ;
Hu, Zhigang ;
Zhang, Jie .
MEDICINAL CHEMISTRY, 2013, 9 (07) :993-998
[37]   Improving buprenorphine treatment outcomes with the L-type calcium channel blocker isradipine [J].
Oliveto, Alison ;
McGaugh, Janette ;
Guise, J. Benjamin ;
Thostenson, Jeff D. ;
Mancino, Michael J. .
DRUG AND ALCOHOL DEPENDENCE, 2017, 171 :E155-E155
[38]   The L-type calcium channel blocker nimodipine mitigates ''learned helplessnes'' in rats [J].
Saade, S ;
Balleine, BW ;
Minor, TR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 74 (02) :269-278
[39]   SOLUTION SYNTHESIS OF CALCISEPTINE, AN L-TYPE SPECIFIC CALCIUM-CHANNEL BLOCKER [J].
KURODA, H ;
CHEN, YN ;
WATANABE, TX ;
KIMURA, T ;
SAKAKIBARA, S .
PEPTIDE RESEARCH, 1992, 5 (05) :265-268
[40]   A molecular dynamics study of an L-type calcium channel model [J].
Barreiro, G ;
Guimaraes, CRW ;
de Alencastro, RB .
PROTEIN ENGINEERING, 2002, 15 (02) :109-122
12345